Erdostein Capsule 300 mg (Erdostein)

Adult dose

Adults: Administer (take) 300 mg of erdosteine per dose orally 2~3 times daily. When used for acute respiratory diseases, do not administer continuously for 10 days or longer.

This medication should not be used in certain patients. First, individuals who have an allergic reaction to this drug or its components should not take it. Second, patients with cirrhosis or those with a deficiency of cystathionine synthase should avoid this medication as its metabolites can affect the body's methionine metabolism. Third, patients with peptic ulcers should also avoid using this medication. Fourth, patients with severely impaired kidney function, i.e., creatinine clearance less than 25 mL/min, should not take this drug. Fifth, patients with severely impaired liver function should also avoid this medication. There are also patients who need caution when using this medication. Patients with slightly or moderately impaired liver function should carefully take this medication not exceeding 300 mg per day. Additionally, this medication contains the dye Yellow 5, and it should be used cautiously if there is an allergy or hypersensitivity to this component. In case of overdose, symptoms such as sweating, dizziness, and flushing may occur. Headaches may occur, and cold symptoms or difficulty breathing may also manifest. Gastrointestinal symptoms like altered taste, nausea, vomiting, diarrhea, upper abdominal pain, abdominal pain, and heartburn may occur. Skin reactions such as hives, erythema, or eczema may appear. Post-marketing studies in South Korea have reported fatigue, indigestion, abdominal pain, gastrointestinal disturbances, diarrhea, vomiting, headaches, regurgitation, erythema nodosum, palpitations, facial or generalized edema, itching, weakness, lethargy, and rashes, though a direct correlation with this medication is uncertain. Caution should be taken if this medication is combined with expectorants, as it may lead to difficulty expelling phlegm from the bronchi because of reduced cough, increasing the risk of bronchial infections and bronchospasm. Pregnant women or women who may become pregnant and breastfeeding women should avoid taking this medication as its safety has not been fully established. This medication should be stored out of reach of children, and transferring it to other containers should be avoided to prevent accidents or compromising the quality of the drug.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

This medication should be discussed with a doctor or pharmacist if used in conjunction with cough medications.

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will safely maintain the drug's effectiveness.

Appearance

Hard capsule with a green upper part and pale yellow lower part containing white powder.

Package unit

30 capsules/bottle, 300 capsules/bottle